Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulation
- PMID: 12748217
- PMCID: PMC1767667
- DOI: 10.1136/heart.89.6.629
Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulation
Abstract
Objective: To investigate the prognostic value of induced monomorphic ventricular tachycardia (VT) and ventricular flutter or fibrillation (VF) during programmed electrical stimulation in patients with a high risk for sudden arrhythmogenic cardiac death.
Design: Prospective cohort study.
Patients: 102 patients at high risk for arrhythmogenic sudden cardiac death who received an automated implantable cardioverter-defibrillator (AICD) were evaluated. 56 patients received the AICD for primary prevention and 46 for secondary prevention. 58 patients had induction of a monomorphic VT (VT group) and 44 had induction of a polymorphic VT, ventricular flutter, or ventricular fibrillation (VF group) during programmed electrical stimulation. Average follow up was 20 months in both groups.
Main outcome measures: Appropriate AICD protocol.
Results: In patients who received the AICD for primary prevention, 16 of 32 patients in the VT group, compared with only four of 24 patients in the VF group, received an appropriate AICD protocol (p = 0.02). In the entire study population, 479 appropriate AICD protocols were recorded in 28 (48%) patients in the VT group and 28 appropriate protocols in 11 (25%) patients in the VF group. Cumulative Kaplan-Meier event-free survival curves were significantly different (p = 0.02).
Conclusion: Induction of VF during programmed electrical stimulation is of no prognostic value even in high risk patients without previously documented ventricular fibrillation.
Figures


Similar articles
-
Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.Europace. 2009 Mar;11(3):289-96. doi: 10.1093/europace/eun330. Epub 2008 Dec 18. Europace. 2009. PMID: 19095687 Clinical Trial.
-
Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.J Cardiovasc Electrophysiol. 2015 Aug;26(8):862-871. doi: 10.1111/jce.12701. Epub 2015 Jun 17. J Cardiovasc Electrophysiol. 2015. PMID: 25929699 Clinical Trial.
-
Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.J Cardiovasc Electrophysiol. 2012 Jul;23(7):750-6. doi: 10.1111/j.1540-8167.2011.02288.x. Epub 2012 Feb 21. J Cardiovasc Electrophysiol. 2012. PMID: 22353378
-
Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):511-8. doi: 10.1111/j.1540-8159.1993.tb01618.x. Pacing Clin Electrophysiol. 1993. PMID: 7681950 Review.
-
Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.Cardiol Clin. 1993 Feb;11(1):97-108. Cardiol Clin. 1993. PMID: 8435827 Review.
Cited by
-
Programmed ventricular stimulation in structural heart disease: Implications of patterns of ventricular arrhythmias induced to long-term outcomes.Indian Heart J. 2023 Jan-Feb;75(1):17-24. doi: 10.1016/j.ihj.2022.12.002. Epub 2022 Dec 26. Indian Heart J. 2023. PMID: 36581158 Free PMC article.
References
-
- AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576–83. - PubMed
-
- Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–40. - PubMed
-
- Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882–90. - PubMed
-
- Wellens HJ, Brugada P, Stevenson WG. Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985;72:1–7. - PubMed
-
- Brugada P, Green M, Abdollah H, et al. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Circulation 1984;69:87–92. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical